When was RUBEDO LIFE SCIENCES founded?

RUBEDO LIFE SCIENCES was founded in 2018 and raised its 1st funding round 2 years after it was founded.

Where is RUBEDO LIFE SCIENCES located?

RUBEDO LIFE SCIENCES is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California.

Who is the current CEO of RUBEDO LIFE SCIENCES?

Marco Quarta of RUBEDO LIFE SCIENCES. They have also founded 1 company.

How many employees does RUBEDO LIFE SCIENCES have?

As of May 31, 2026, the latest employee count at RUBEDO LIFE SCIENCES is 34.

Is RUBEDO LIFE SCIENCES a funded company?

RUBEDO LIFE SCIENCES is a funded company, having raised a total of $52M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 03, 2020.

When was the latest funding round of RUBEDO LIFE SCIENCES?

RUBEDO LIFE SCIENCES's latest funding was a $***** Series A round on Apr 22, 2024, with participation from 10 investors.

Where does RUBEDO LIFE SCIENCES rank among its competitors?

RUBEDO LIFE SCIENCES ranks 4th amongst 155 active competitors, of which 47 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Acumen Pharmaceuticals, which secured $35.7M in Mar, 2026.

Who are the top competitors of RUBEDO LIFE SCIENCES?

RUBEDO LIFE SCIENCES's top competitors include Drug Farm, Alzheon and LEXEO Therapeutics. Among them, Acumen Pharmaceuticals secured the most recent funding round in March, 2026.

RUBEDO LIFE SCIENCES - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of therapeutics for age-related diseases. The company uses propriety technology includes the ALEMBIC that focuses on developing medicines to combat biological aging by targeting pathologic cells like senescent ones that drive age-related diseases.

Website: rubedolife.com
Social
Email ID: *****@rubedolife.com
Registered Address: Sunnyvale, California

Key Metrics

Founded Year

2018

Location

Sunnyvale, United States

Stage

Series A

Total Funding

$52M in 2 rounds

Latest Funding Round

Series A, Apr 22, 2024, $*****

Investors

Khosla Ventures & 12 more

Ranked

4^th among 155 active competitors

Employee Count

34 as on May 31, 2026

Similar Companies

Drug Farm & 146 more

View RUBEDO LIFE SCIENCES's full profile

RUBEDO LIFE SCIENCES is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Rubedo Life Sciences, Inc. CIN: 824352074 , United States, Active	Dec 31, 1999	-	28 (As on Dec 31, 2024)	-

RUBEDO LIFE SCIENCES has raised a total funding of $52M over 2 rounds. Its first funding round was on Dec 03, 2020. Its latest funding round was a Series A round on Apr 22, 2024 for $*****. 10 investors participated in its latest round. RUBEDO LIFE SCIENCES has 13 institutional investors.

Here is the list of recent funding rounds of RUBEDO LIFE SCIENCES:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 22, 2024	9563977	Series A	1555453	2753559	1443781	1142532
Dec 03, 2020	9027003	Seed	4477205	2327221	Khosla Ventures	The Longevity Fund & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of RUBEDO LIFE SCIENCES's funding rounds and investors

The founders of RUBEDO LIFE SCIENCES are Marco Quarta, Mark Gallop and Julian Klein. Marco Quarta is the CEO of RUBEDO LIFE SCIENCES.

Here are the details of RUBEDO LIFE SCIENCES's key team members:

Marco Quarta: Co-Founder & CEO of RUBEDO LIFE SCIENCES.
Contact Info: 1 email address
Mark Gallop: Co-Founder of RUBEDO LIFE SCIENCES.
Contact Info: 1 email address
Julian Klein: Co-Founder of RUBEDO LIFE SCIENCES.
Contact Info: 1 email address

View details of RUBEDO LIFE SCIENCES's Founder profiles and Board Members

RUBEDO LIFE SCIENCES's employee count trend

RUBEDO LIFE SCIENCES has 34 employees as of May 26. Here is RUBEDO LIFE SCIENCES's employee count trend over the years:

Employee count trend for RUBEDO LIFE SCIENCES

Uncover RUBEDO LIFE SCIENCES's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of RUBEDO LIFE SCIENCES include Drug Farm, Alzheon and LEXEO Therapeutics. Here is the list of Top 10 competitors of RUBEDO LIFE SCIENCES, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Drug Farm 2015, Shanghai (China), Series C	Developer of a novel treatment for metabolic diseases	$83M	Zhejiang Private Enterprise United Investment, BioVeda China Fund ... & 7 others	63/100
2nd	Alzheon 2013, Framingham (United States), Series E	Developer of disease-modifying treatments for Alzheimer's disease and other neurodegenerative disorders	$195M	Ally Bridge Group, Alerce Medical Technology Partners ... & 4 others	62/100
3rd	LEXEO Therapeutics 2018, New York City (United States), Public	Developer of gene therapy for the treatment of CLN2 Batten and Alzheimer's diseases	$185M	Eventide Funds, Omega Funds & 26 others	61/100
4th	RUBEDO LIFE SCIENCES 2018, Sunnyvale (United States), Series A	Developer of therapeutics for age-related diseases	$52M	Khosla Ventures, The Longevity Fund & 11 others	61/100
5th	Cassava Sciences 1998, Austin (United States), Public	Developer of small molecule-based therapeutic solutions for treating neurological diseases	-	Kosinski Ventures, NIH & 1 others	59/100
6th	Cerecin 2001, Singapore (Singapore), Series C	Developer of medical food and drugs for Alzheimer's disease	$255M	Inventages, SK Securities & 11 others	57/100
7th	Acumen Pharmaceuticals 1996, Livermore (United States), Public	Developer of monoclonal antibody therapeutics for Alzheimer's disease	$2.2M	ADAR1, Western Technology Investment & 6 others	56/100
8th	Newronika 2016, Cologno Monzese (Italy), Series B	Developer of devices for neurodegenerative diseases	$25.2M	Omnes Capital, Innogest Capital & 9 others	56/100
9th	OncoC4 2020, Rockville (United States), Series B	Developer of immunotherapy for cancer patients	$50M	GBA Fund, 3E Bioventures Capital & 4 others	56/100
10th	MindImmune Therapeutics 2016, Ledyard (United States), Series A	Developing immunotherapeutics to restore neural connections in neurodegenerative diseases	$33.9M	Dolby Family Ventures, Trend-venture.com & 6 others	56/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on RUBEDO LIFE SCIENCES's competitors? Click here to see the top ones

RUBEDO LIFE SCIENCES has made no investments or acquisitions yet.

Here is the latest report on RUBEDO LIFE SCIENCES's geography:

Free

US Fintech Quarter Funding Report

Edition: Quarter 1, 2026 (41 Pages)

View all reports related to RUBEDO LIFE SCIENCES

Media has covered RUBEDO LIFE SCIENCES for a total of 6 events in the last 1 year, 3 of them have been about company updates and 1 about partnerships.